Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Robert P. Hof"'
Publikováno v:
Transplantation. 78:345-351
Background We recently demonstrated that donor medial cells are replaced by smooth muscle alpha-actin (SMA)-expressing host cells in murine carotid allografts. In this study, we investigated neointimal cell dynamics including effects of cyclosporine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640f2d920fd142320a3de6e7a9bf81a0
https://doi.org/10.1097/01.tp.0000128610.93598.80
https://doi.org/10.1097/01.tp.0000128610.93598.80
Publikováno v:
Transplantation. 76:1166-1170
Background Apolipoprotein E-deficient (apoE-/-) mice spontaneously develop hypercholesterolemia and atherosclerotic lesions. This may be an appropriate background for the development of graft vessel disease. The authors therefore investigated the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91ec426946821adb339e3015b0cebb07
https://doi.org/10.1097/01.tp.0000090393.75600.32
https://doi.org/10.1097/01.tp.0000090393.75600.32
Publikováno v:
Transplant Immunology. 9:43-49
Objective: The macrolide immunosuppressant RAD and the immunomodulator FTY720 have distinct mechanisms of action. We investigated the efficacy of RAD (everolimus, certican®) alone or in combination with FTY720 on graft survival (GS) and histology in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e308f9b7e6f49238409aa931cd1e261
https://doi.org/10.1016/s0966-3274(01)00045-4
https://doi.org/10.1016/s0966-3274(01)00045-4
Publikováno v:
Transplant Immunology. 8:115-124
Objective: The new immunomodulator 2-amino-2-(2-{4-octylphenyl}ethyl)-1,3-propanediol hydrochloride (FTY720) lowers the peripheral lymphocyte count (PLC) by inducing migration of circulating lymphocytes to secondary lymphoid organs. This effect is do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3fe3957199ecb26d6321659eb363ebf
https://doi.org/10.1016/s0966-3274(00)00016-2
https://doi.org/10.1016/s0966-3274(00)00016-2
Publikováno v:
Transplantation. 64:20-27
BACKGROUND: Graft vessel disease is a special form of accelerated arteriosclerosis. Because immunological and nonimmunological factors can contribute to graft vessel disease, we developed a model that enables the study of both factors simultaneously.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de91f8752489b21db46aec8c0dc942b1
https://doi.org/10.1097/00007890-199707150-00005
https://doi.org/10.1097/00007890-199707150-00005
Autor:
Richard M. Kellogg, Robert P. Hof
Publikováno v:
Tetrahedron: Asymmetry. 5:565-568
Several racemic 1,2-diols bearing a tertiary benzylic alcohol stereogenic center can be esterified regioselectively by vinyl acetate using lipases and esterases in organic media. With the correct choice of enzyme and if the non-phenyl substituent at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25467451d1ff23db6b908225569a6c74
https://doi.org/10.1016/0957-4166(94)80019-7
https://doi.org/10.1016/0957-4166(94)80019-7
Publikováno v:
Cardiovascular Drugs and Therapy. 8:235-244
The effects of the new inotropic agent, SDZ 218-135 [(+)-(S)-4-[3-(4-diphenyl-methyl-1-piperazinyl)-2-hydroxy-propyl]- 6-(2-hydroxyethyl)-5-methyl-1,2,4-triazolo-[1,5-a]pyrimidin-7(4H)-one], were investigated using in vitro and in vivo techniques. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6a0a6238afb258359c02ba1ace57aec
https://doi.org/10.1007/bf00877332
https://doi.org/10.1007/bf00877332
Publikováno v:
Cardiovascular Research. 28:215-220
Objective: Both calcium antagonists and angiotensin converting enzyme (ACE) inhibitors are known to diminish the development of intimal thickening after a balloon catheter lesion. It was previously shown that narrowing of carotid artery lumen induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6e7c74b64e62a559139677f451b0fe
https://doi.org/10.1093/cvr/28.2.215
https://doi.org/10.1093/cvr/28.2.215
Publikováno v:
Journal of Cardiovascular Pharmacology. 22:499-505
Tropisetron (ICS 205-930) is a novel drug that blocks serotonin (5-HT3) receptors and, at higher concentrations, potassium channels. Programmed electrical stimulation (PES) and tracer microspheres were used to investigate antiarrhythmic, systemic, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32248317cbf0b311dea513ea6928c48a
https://doi.org/10.1097/00005344-199309000-00023
https://doi.org/10.1097/00005344-199309000-00023
Autor:
E Robertson, Evenou Jp, Markus Rudin, Stirnimann R, Robert P. Hof, Zierhut W, Zerwes Hg, Novosel D
Publikováno v:
Journal of Cardiovascular Pharmacology. 21:937-946
Structural alterations after myocardial infarction (MI) in rats are usually examined only after death of the experimental animal. Magnetic resonance imaging (MRI) allows repeated and noninvasive measurements of important structural [left ventricular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328c3e75d04cd3118de80356397672ed
https://doi.org/10.1097/00005344-199306000-00014
https://doi.org/10.1097/00005344-199306000-00014